Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

Clinical trial NCT05184842 · RECRUITING

Trial details

NCT number: NCT05184842
Sponsor: Montefiore Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia

Start date: 2022-03-23
Primary completion: 2023-12-20
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.